Optum Ventures joins Vera Health's $28.5M round, and buys a look at the evidence layer clinicians use
Optum Ventures joined Vera Health's $28.5 million Series A, a small check in a free clinical search engine used by 800,000 clinicians that gives UnitedHealth a look at the evidence layer at the point of care.
Vera Health has raised $28.5 million in a Series A round led by Threshold Ventures, with Optum Ventures, Mantis VC and SV Angel participating and existing backers Y Combinator and Gradient tripling their positions. The round was announced on October 27, 2026 and brings the company's total funding to $32 million. 12
Optum Ventures is the venture firm founded in 2017 in partnership with UnitedHealth Group, with more than $2 billion under management across six funds and 75-plus portfolio companies. 3 Its participation gives the insurer's parent a seat beside the tool that 800,000 clinicians already open at the point of care. Nothing published obliges UnitedHealth to use, resell or buy what Vera builds.
Deal card
| Field | What is known |
|---|---|
| Announced | October 27, 2026. 1 |
| Round size | $28.5 million Series A, taking total funding to $32 million. 2 |
| Lead | Threshold Ventures. 1 |
| Participating | Optum Ventures, Mantis VC, SV Angel; Y Combinator and Gradient tripled their investments. 2 |
| Terms and stake | Percentage, valuation and board rights were not published. 12 |
| Use of funds | Evidence infrastructure, international expansion, partnerships and hiring. 1 |
| Investor profile | Optum Ventures: independent fund, $2 billion across six funds, 75-plus companies, stage-agnostic from seed to growth equity. 3 |
What Vera sells
Vera is a clinical search engine. A clinician types a question, and the system retrieves from more than 60 million peer-reviewed papers, guidelines, consensus statements and drug labels, then writes a short answer with each claim linked to its source. 14
The order of those two steps is the product. The retrieval layer grades each source on study design, sample size, cohort power, publication recency, journal impact and citation velocity, and colours each statement by the strength of the evidence behind it, so a claim resting on a small case series reads differently from one resting on a randomised trial. 2 Co-founder Taieb Bennani described the design to Fierce Healthcare as a search engine that finds the evidence first and writes the answer second. 1
Two additions push it toward hospitals. Vera has an institutional partnership with the American College of Emergency Physicians, which puts that society's clinical policies and decision trees inside search results with attribution. 2 Vera Spaces, which the company says it is rolling out, lets a hospital load its own order sets, formulary restrictions and departmental protocols alongside the global literature, so an answer about antibiotic dosing reflects the local antibiogram. 2
The product is free to licensed clinicians and trainees, permanently, on the company's account. 2
What the traction numbers support
A year ago Vera counted a few thousand clinicians. It now reports more than 800,000 across 190 countries, with about one in four practising physicians in Spain and Italy and one in seven in France, reached mostly through colleagues rather than sales. 12
The company says Vera has been the most-downloaded clinical app worldwide in every month since June 2026 and that September downloads exceeded OpenEvidence and Doximity combined. 1 It did that with 12 employees and, by its own account, no enterprise marketing budget. 2
Those are company figures, repeated by trade press, with no third-party audit behind them. Downloads also measure interest rather than habit, and a free product generates no revenue line from the clinicians who use it. The number that would tell an investor whether Vera has a business is the count of paying health systems, and that has not been disclosed.
Why Optum Ventures would write this check
Optum Ventures sits inside the healthcare ecosystem in a way most funds cannot. Its stated advantage is connectivity across UnitedHealth Group, health plans, providers and employers, plus commercialisation help for portfolio companies. 3 For a 12-person company selling to hospitals, that access is worth more than the cash.
The strategic adjacency runs through Optum Insight, the segment that sells software and analytics to providers and payers. Optum Insight reported $5.5 billion of revenue in the third quarter of 2026, up 3%, with $1.3 billion of earnings from operations, and the company describes it as bringing AI-enabled products to market for clinical documentation and payment accuracy. 5
A clinician-facing evidence layer fits that portfolio as a possible module, a possible acquisition target, or simply a view into how doctors are starting to ask questions. Fierce Healthcare's list of Vera's competitors makes the strategic reading sharper: Elsevier's ClinicalKey and Wolters Kluwer's UpToDate, the paid clinical reference incumbents, alongside OpenEvidence and Doximity Ask on the AI-native side, and OpenAI and Anthropic at the general-purpose end. 1
Where the money has to come from
Vera gives the reference layer away to individual clinicians and plans to earn from the enterprise side, through Spaces and institutional partnerships. 2
OpenAI and Anthropic now sit on the competitor list Fierce Healthcare compiled, which puts free general models at the edge of Vera's market. Owning the default for 800,000 clinicians is a credible bid to get there first, before hospitals sign another multi-year renewal. It also means Vera's revenue depends on convincing hospital systems that local protocol integration and evidence grading are worth paying for, which is a procurement argument rather than a consumer one.
The other constraint is credibility of the grading itself. Vera's pitch rests on telling a doctor when the evidence is thin. That promise gets tested the first time a hospital adopts it as a decision-support layer and a clinician follows a statement that turns out to be wrong, which is why the citation trail and the local-protocol layer carry more weight than the underlying model.
What it changes for the sector
A company with 12 employees reached 800,000 clinicians in more than 190 countries within a year, in a market where enterprise health software is normally sold by large field teams over long cycles. That is the part incumbents have to answer, because it happened at the level of individual clinicians rather than hospital contracts.
For UnitedHealth, the meaning is narrower. Optum Ventures is an independent fund, the check is small relative to its $2 billion, and nothing published commits Optum or UnitedHealthcare to using, reselling or acquiring Vera. What the round shows is where the parent's venture arm sees durable value in clinical AI: ranked, sourced evidence and local protocol.
What to watch next
- Named Spaces customers: the first hospital or health system that publicly runs Vera Spaces is the signal that the enterprise model converts downloads into contracts. 2
- Optum Insight distribution: any arrangement to carry Vera inside Optum's provider software would turn a financial position into a strategic one. 5
- Usage rather than downloads: published active-clinician counts, query volume or retention, which the company has so far described in download rankings only. 1
- Medical society partnerships: ACEP is the first; each additional society makes the embedded-policy layer harder to copy. 2
- Competitor pricing: whether UpToDate, ClinicalKey, OpenEvidence or Doximity respond with free tiers of their own. 1
- Next round: the valuation set at Series B will show whether investor belief in free-to-clinician distribution survived contact with a year of usage data. 1
Vera turned a search box into a distribution channel and convinced a payer-linked fund to buy in. The next disclosure that matters is how many hospitals pay for it.
References
- 1Vera Health secures $28.5M series A for AI-driven clinical search engine
fiercehealthcare.com
- 2
- 3About — Optum Ventures
optumventures.com
- 4Vera Health — evidence-based clinical answers
verahealth.ai
- 5UnitedHealth Group Reports Third Quarter 2026 Results
unitedhealthgroup.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.